1. Singapore Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - General
Haw Par Corporation Limited

Haw Par Corporation Limited

HAWPY
Haw Par Corporation LimitedUS flagOther OTC
53.50
USD
- -
- -
2.96BMarket Cap
Haw Par Corporation Limited
HAWPY
(Other OTC)

Recent

price

53.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2.39
2.44
2.56
2.58
2.82
3.27
3.68
4.05
4.31
4.42
2.01
2.55
3.29
4.19
4.42
4.16
4.42
Revenue per Share
2.07
1.47
2.2
1.98
2.17
3.35
2.28
2.23
3.25
3.3
2.17
1.99
2.68
3.91
4.12
4.8
3.3
Basic EPS, GAAP
0.61
0.83
1.53
1.68
1.02
2.25
1.62
1.1
1.2
1.47
0.32
0.26
0.38
0.99
0.91
0.99
1.47
Free Cash Flow per Basic Share
0.73
0.73
0.73
0.75
0.8
0.8
1.56
0.8
1
4.6
1.2
1.2
1.2
1.4
1.6
5.6
4.6
Dividend per Share
4.44
4.45
18.15
19.38
20.76
23.37
21.13
23
26.09
24.86
26.09
26.89
28.36
30.87
33.39
32.59
24.87
Book Value per Share
35.84
32.65
41.16
44.54
51.1
46.08
42.21
55.79
52.88
56.92
51.98
57.85
63.92
62.61
74.76
77.34
56.94
Tangible Book Value per Share
54
54
54
55
55
55
55
55
55
55
55
55
55
55
55
55
55
Basic Weighted Avg Shares
130
133
139
141
154
179
202
223
238
244
111
141
182
232
245
230
244
Sales/Revenue/Turnover
26.64
23.71
22.87
26.49
27.87
29.79
35.75
32.18
35.01
32.35
12.55
17.49
23.82
27.58
26.08
29.17
32.35
Operating Margin (%)
5
6
5
5
5
5
3
6
6
6
7
6
6
6
6
6
6
Depreciation Expense
113
80
120
108
119
183
125
122
179
182
120
110
148
217
228
265
182
Net Income, GAAP
8.88
7.21
5.78
6.38
6.41
5.36
9.95
11.16
6.87
7.49
3.57
5.23
6.7
5.59
7.25
5.75
7.49
Effective Tax Rate (%)
86.7
60.15
86.09
76.44
77.05
102.48
62.01
54.97
75.3
74.68
107.87
77.99
81.45
93.32
93.24
115.43
74.68
Profit Margin (%)
435
370
481
572
621
631
2,276
3,046
2,826
3,063
2,775
3,100
3,153
3,190
3,915
4,165
3,063
Working Capital
- -
- -
- -
- -
- -
- -
46
45
- -
9
1
1
29
28
37
45
9
LT Debt
1,960
1,789
2,253
2,445
2,807
2,535
2,325
3,078
2,928
3,156
2,885
3,211
3,549
3,476
4,149
4,291
3,156
Total Equity
1.62
1.55
1.47
1.47
1.5
1.85
2.59
2.27
2.52
2.37
0.44
0.77
1.19
1.7
1.53
1.47
2.37
Return on Invested Capital (%)
45.28
31.58
18.99
10.33
10.48
14.6
9.74
9.43
12.73
12.78
8.46
7.51
9.64
13.07
12.59
14
12.78
Return on Capital (%)
46.79
33.01
19.5
10.54
10.83
15.17
10.26
10.11
13.24
12.95
8.51
7.52
9.7
13.21
12.84
14.54
12.95
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'19
Sep'19
Dec'19
ST Debt
24
24
9
LT Borrowings
24
24
8
LT Finance Leases
- -
- -
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
221
221
221
Market Capitalization
2,622
2,707
2,636

Working Capital

FRC

•

in mil. unless spec.
Jun'19
Sep'19
Dec'19
Total Current Assets
3,045
3,030
3,138
Cash, Cash Equivalents & STI
2,975
2,969
3,087
Accounts Receivable, Net
49
41
24
Inventories
22
19
20
Total Current Liabilities
102
102
75
Payables & Accruals
- -
- -
- -
ST Debt
24
24
9
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.1%
8.51%
3.44%
Free Cash Flow
8.3%
37.85%
9.3%
Net Income, GAAP
7.42%
18.87%
16.29%
Sales/Revenue/Turnover
6.11%
16.6%
-6.07%
Total Cash Common Dividend
63.98%
56.21%
250%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
232
2024
- -
- -
- -
- -
245
2025
- -
- -
- -
- -
230

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
3.91
2024
- -
- -
- -
- -
4.12
2025
- -
- -
- -
- -
4.8

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.4
2024
- -
- -
- -
- -
1.6
2025
- -
- -
- -
- -
5.6
Similar Companies
GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS)
AstraZeneca PLC (AZN)
MIRA Pharmaceuticals, Inc. (MIRA)
Yung Zip Chemical Ind. Co., Ltd. (4102.TWO)
Qingdao Baheal Medical Inc. (301015.SZ)
Zoetis Inc. (0M3Q.L)
Business
Haw Par Corporation Limited, along with its associated entities, engages in the creation, promotion, and distribution of wellness solutions across Singapore, ASEAN nations, other Asian markets, and internationally. The company organizes its operations into distinct divisions: Healthcare, Investments, and a composite segment designated as Others. The Healthcare division is primarily dedicated to the manufacturing and marketing of renowned topical pain relief products under the established brand names of Tiger Balm and Kwan Loong. Its Investments arm strategically allocates capital into publicly traded securities for long-term growth. Furthermore, the company manages and rents out various commercial and industrial real estate assets, encompassing properties such as Haw Par Centre and Menara Haw Par in Singapore and Malaysia. Additionally, the Others segment includes leisure offerings that cater to families and tourists, prominently featuring oceanariums like Underwater World Pattaya. Haw Par Corporation Limited also facilitates property rental services and offers management support. The firm was established in Singapore in 1969.